Videlis Nduba
Biographic Data
| ID | 7762142 |
|---|---|
| NAME | Videlis Nduba |
| GIVEN NAMES | Videlis |
| FAMILY NAME | Nduba |
| SIGNATURE | NDUBA V |
| AFFILIATIONS | Centers for Disease Control and Prevention |
| ORCID | 0000-0002-2266-8349 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Persistently high TB prevalence in Nairobi County neighbourhoods, 2015–2022
National and sub-national population-based surveys, when performed at intervals, may assess important changes in TB prevalence. In 2022 we re-surveyed nine Nairobi County neighbourhoods that were previously surveyed in 2015. We aimed to determine pulmonary TB prevalence, compare prevalence to 2015 estimates, and evaluate changes in risk groups. Participants who reported cough of any duration and/or whose chest x-ray suggested TB submitted sputum …
Development of a TB vaccine trial site in Africa and lessons from the Ebola experience
Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy against Ebola. The developments that led to the trialing of the Ebola vaccine were historic and unprecedented. The single licensed TB vaccine (BCG) has limited effi…
No prominent works on this page.
Development of a TB vaccine trial site in Africa and lessons from the Ebola experience
Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy against Ebola. The developments that led to the trialing of the Ebola vaccine were historic and unprecedented. The single licensed TB vaccine (BCG) has limited effi…
Persistently high TB prevalence in Nairobi County neighbourhoods, 2015–2022
National and sub-national population-based surveys, when performed at intervals, may assess important changes in TB prevalence. In 2022 we re-surveyed nine Nairobi County neighbourhoods that were previously surveyed in 2015. We aimed to determine pulmonary TB prevalence, compare prevalence to 2015 estimates, and evaluate changes in risk groups. Participants who reported cough of any duration and/or whose chest x-ray suggested TB submitted sputum …
Environmental health (2 works) · Medicine (2 works) · Pathology (2 works) · Tuberculosis (2 works) · Clinical trial (1 work) · Confidence interval (1 work) · Demography (1 work) · Ebola vaccine (1 work) · Ebola virus (1 work) · Immune responses and vaccinations (1 work)